HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,526,202 | -40.6% | 598,046 | +0.3% | 0.28% | -35.1% |
Q4 2022 | $32,850,179 | +12.9% | 596,192 | -9.3% | 0.44% | +4.3% |
Q3 2022 | $29,107,000 | -15.0% | 657,188 | -6.4% | 0.42% | -13.6% |
Q2 2022 | $34,240,000 | +463.3% | 702,068 | +461.8% | 0.48% | +581.7% |
Q1 2022 | $6,079,000 | +17.7% | 124,961 | +3.1% | 0.07% | +34.0% |
Q4 2021 | $5,166,000 | +4.2% | 121,161 | -6.3% | 0.05% | +6.0% |
Q3 2021 | $4,956,000 | – | 129,289 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |